SIMPEX 2017, pharmaceutical healthcare companies.#Pharmaceutical #healthcare #companies

Posted On Jun 12 2018 by

SIMPEX PARTNERS STRATEGIC PARTNER POST SANCTIONS ERA – Sudan Presents An Ocean of Opportunities Post lifting of US Trade sanctions, ​​Sudan ​is ​purs​u​​ing​ a strategy of establishing itself as a hub for Arab-African trade.​ The decision is set to ​drastically improve the business environment and drive the growth of Sudan’s economy​.​ In particular, ​the ability to transfer funds in and out of the country, previously restricted for both US and non-US companies, is set to ​give a major thrust to the business as more and more banks recommence processing Sudan-linked payments.​ Since last few weeks there has been a huge …


Home Page, PhRMA, pharmaceutical healthcare companies.#Pharmaceutical #healthcare #companies

Posted On Jun 12 2018 by

pharmaceutical healthcare companies PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource …


Attorney General: Connecticut Leads 20 State Coalition Filing Federal Antitrust Lawsuit against Heritage Pharmaceuticals, other Generic Drug Companies, generic pharma companies.#Generic #pharma #companies

Posted On Jun 10 2018 by

generic pharma companies HARTFORD – Attorney General George Jepsen today joined with 19 other state attorneys general in filing a federal lawsuit against generic drug-makers Heritage Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. alleging that they entered into illegal conspiracies in order to unreasonably restrain trade, artificially inflate and manipulate prices and reduce competition in the United States for two drugs: doxycycline hyclate delayed release, an antibiotic, and glyburide, an oral diabetes medication. The lawsuit was filed under seal in the U.S. District Court for the …


Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, generic pharma companies.#Generic #pharma #companies

Posted On Jun 9 2018 by

Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA About us Cadila Pharmaceuticals Limited, established in …


Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jun 9 2018 by

Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA About us Cadila Pharmaceuticals Limited, established in …


20 States Accuse Generic Drug Companies of Price Fixing, generic pharma companies.#Generic #pharma #companies

Posted On Jun 9 2018 by

The New York Times A wide-ranging investigation into generic drug prices took its most significant turn yet on Thursday, as state attorneys general accused two industry leaders, Teva Pharmaceuticals and Mylan, and four smaller companies of engaging in brazen price-fixing schemes — and promised that more charges were coming. A civil complaint filed by 20 states accuses the companies of conspiring to artificially inflate prices on an antibiotic and a diabetes drug, with executives coordinating through informal industry gatherings and personal calls and text messages. Officials said the case was a small example of broader problems in the drug business. …


NYS Professions – Online Verifications, health it companies.#Health #it #companies

Posted On Jun 8 2018 by

Office of the Professions Verifications Written Certification/ Verification of Licensure Office of the Professions Fee Schedule Verification Searches The information furnished at this web site is from the Office of Professions’ official database and is updated daily, Monday through Friday. The Office of Professions considers this information to be a secure, primary source for license verification. Search by name within a profession: Select a profession. Enter a minimum of 3 characters of the person s name, with the last name first (separated by a space, not a comma). When a last name consists of only two letters, you must also …


20 States Accuse Generic Drug Companies of Price Fixing – The New York Times, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jun 8 2018 by

20 States Accuse Generic Drug Companies of Price Fixing A wide-ranging investigation into generic drug prices took its most significant turn yet on Thursday, as state attorneys general accused two industry leaders, Teva Pharmaceuticals and Mylan, and four smaller companies of engaging in brazen price-fixing schemes — and promised that more charges were coming. A civil complaint filed by 20 states accuses the companies of conspiring to artificially inflate prices on an antibiotic and a diabetes drug, with executives coordinating through informal industry gatherings and personal calls and text messages. Officials said the case was a small example of broader …


Biotech Industry, Biotech News, Biotechnology Articles, top 20 pharma companies.#Top #20 #pharma #companies

Posted On Jun 7 2018 by

top 20 pharma companies Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms. Toxicity knocks Ardelyx s hyperkalemia hopes back to preclinic Unexpected side effects have spelled the end for Ardelyx’s drug candidate to treat elevated potassium levels in the blood, which was in phase 3 testing. Cytokinetics cans lead drug after phase 3 ALS wipeout Cytokinetics canned tirasemtiv after it failed to beat placebo against the primary endpoint or any of the secondary goals in an ALS trial. Step Pharma bags cash for CTPS1 autoimmune R …


SRS Pharmaceuticals Pvt, pharmaceutical companies india.#Pharmaceutical #companies #india

Posted On Jun 7 2018 by

pharmaceutical companies india Our products are available to local pharmaceutical distributors in most countries. Our products are available under private label to our distributors and partners. We work with our distributors, strategically programmatically, to accelerate, expand extend the product life cycles of ethical drugs. We can provide, clinical Trials, FDA Certificates and BE Studies for registration of our products as per guidelines of most health authorities in most countries.